Chapter 30: Lower Respiratory Problems

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome to the Deep Dive.

We're here to cut through the noise of dense med -circ topics and pull out what you, as future nurses, really need to know.

Today, we're tackling a big one.

Lower respiratory problems.

Using Lewis's Medical Surgical Nursing as our guide, our mission.

Give you the essential insights, those practical takeaways, maybe even a few surprising facts to help you really grasp this stuff.

So, okay, let's unpack this chapter.

We're talking about a whole range of conditions affecting the lower respiratory tract.

These are diseases that directly mess with gas exchange.

Think bronchitis, pneumonia,

TB, even things like P .E.

and lung cancer.

They all impact that fundamental need for oxygen and getting rid of CO2.

Pretty critical stuff.

Absolutely critical.

And what we want to do today is really connect the pathophysiology, the why behind the disease, directly to what you do as a nurse.

So, assessment, identifying priorities, collaborating with the whole team, and crucially, patient education.

It's fascinating, really, how we can break down this complex medical information into clear, actionable knowledge for your clinical practice and, yeah, for that NCLA -X way of thinking, too.

Okay, let's start with lower respiratory tract infections.

These are common, and they can be really serious.

I mean, just think, pneumonia and flu cause around 50 ,000 deaths a year in the US alone.

That's significant.

Let's begin with acute bronchitis.

Right, so acute bronchitis is basically an inflammation of the bronchi.

It's usually self -limiting, meaning it resolves on its own, most often caused by viruses, though things like air pollution, smoking, chemical irritants, those can trigger it, too.

And clinically, what you'll often see is that persistent cough.

It can hang around for, like, up to three weeks, often feels worse at night.

Patients might have some sputum, maybe purulent, maybe not, headache, maybe a low fever, malaise, just feeling generally run down.

Your assessment might find normal breath sounds or maybe some crackles or wheezes.

Usually, the chest x -ray is clear unless pneumonia is suspected.

And here's a really key point, especially for patient teaching.

Treatment is supportive.

You know, cough suppressants may be effective.

Definitely, fluid humidifiers can help.

But, and this is where it gets interesting, antibiotics are generally not the answer for viral bronchitis.

Right, big push against antibiotic resistance.

Exactly.

So, unless your patient has other chronic lung issues or looks systemically unwell, you're explaining why antibiotics aren't needed.

Your teaching focuses on rest, fluids, avoiding smoke, good hand washing, and telling them when to call back, like if they spike a high fever, get short of breath, or if symptoms drag on past four weeks.

Okay, moving on to pertussis.

Whooping cough,

highly contagious caused by bordetella pertussis.

And worryingly, we've seen more cases in teens and adults since the 80s, probably because immunity from childhood vaccines wears off.

Yeah, that waning immunity is a real issue.

It's why the CDC strongly recommends the PDAP booster for adolescents and adults.

It's not just a childhood disease anymore.

Pertussis has stages.

It starts kind of sneaky, like a mild cold, for a week or two.

Then comes the really characteristic part, those paroxysms.

Weeks like two to 10 weeks of these violent, uncontrollable coughing fits, often with that classic whoop sound when they gasp for air afterwards.

Though importantly,

vaccinated people might not have the whoop, but they can still have pertussis.

The cough itself can last a long time, six to 10 weeks even.

Wow, that's a long time to be coughing like that.

Diagnosis.

Usually based on the history and symptoms in the community.

In the hospital, you might do nasopharyngeal cultures or PCR tests.

And treatment is antibiotics, specifically macrolides.

Correct.

And a key nursing point.

These patients are infectious for a good while, through the third week of illness or until they've had five days of antibiotics.

So droplet precautions are a must.

Absolutely.

And another tough thing for patients, cough suppressants don't really help with that specific type of cough.

It's frustrating for them.

Okay, let's pivot to pneumonia.

This is a huge topic.

An acute infection of the lung tissue itself.

Still a leading cause of death globally, you will see this.

You will.

Our lungs have amazing defenses, right?

The cough reflex, the cilia moving mucus up and out that mucosillary escalator, the macrophages and the alveoli cleaning things up.

Pneumonia happens when these defenses get overwhelmed or bypassed.

Pathogens can get down there through aspiration maybe of normal throat bacteria or inhaling microbes or sometimes even spreading through the blood from an infection elsewhere.

And we classify it mainly as community -acquired CAP or hospital -acquired HAP.

The key difference is timing.

CAP means you weren't in a hospital or long -term care facility for 14 days before symptoms started.

HAP develops 48 hours or more after admission.

And that distinction is critical.

Why?

It guides the initial antibiotic choice, right?

Because the likely bugs are different.

Exactly.

It tells us what therapy to start.

And think about who's at risk cable 30 .1 in Lewis lists them.

But key ones are age over 65,

altered consciousness, chronic diseases like CPD or diabetes,

smoking, recent surgery, being on a ventilator.

These patients need close watching.

And there are different types too.

Viral is actually the most common overall.

Right.

Then you have aspiration pneumonia, which is a huge nursing concern, especially with patients who have trouble swallowing or a poor gag reflex.

Necrotizing pneumonia is rare, but very severe, often a complication bacterial lung infection.

And then opportunistic pneumonias like pneumocystis, Girovace pneumonia or PJP and CMV pneumonia, those hit immunocompromised patients hard.

So what does pneumonia look like clinically?

Often it's cough productive or not.

Sputum can be green, yellow, even rusty fever, chills, shortness of breath, fast breathing, maybe pleuritic chest pain that hurts when you breathe in.

But here's a critical insight, especially for you working with older adults or very debilitated patients.

They might not show those classic signs.

What might they show instead?

Confusion, stupor,

maybe hyperthermia instead of fever.

That change in mental status might be your only clue that they're hypoxic from pneumonia.

It's a real game changer for assessment.

That's huge.

On assessment, you might hear crackles or if there's consolidation where the lung tissue fills with fluid, you might hear bronchial breath sounds where you shouldn't or something called egophany.

And complications.

Well, they can be serious.

Multi -drug resistant organisms, MDR pathogens like MRSA or resistant gram negatives are a growing nightmare.

They increase mortality significantly.

Other potential problems include pleurisy, pleural effusion fluid around the lung bacteremia, a collapsed lung or pneumothorax, respiratory failure, sexus, even lung abscess or empima, which is pus in the pleural space.

So diagnostics like you see in table 30 .4.

Test x -ray is usually the first step, often shows telltale patterns.

Sputum culture helps identify the specific bug.

Right.

The gold standard for identifying the pathogen.

But, and this is vital for nurses.

Don't delay starting antibiotics while waiting for the culture results.

Exactly.

Prompt empiric therapy is key.

ABGs can show hypoxemia, maybe high CO2 later.

White blood cell count is usually up.

Sometimes newer markers like C -reactive protein or procalcitonin are used too.

So care involves getting the right antibiotics started quickly, then tailoring them once cultures are back.

Supportive care for viral pneumonia.

And don't forget nutrition and hydration.

Fluids help thin secretions make them easier to cough up.

But be careful with IV fluids in older adults or heart failure patients.

You don't want to cause fluid overload.

Good point.

And for those who are short of breath, small, frequent meals that are high in calories and nutrients are usually better tolerated.

Nursing management, as laid out in table 30 .7 and 30 .8, is all about assessment and intervention.

Your assessment is SURO, health history, any chronic lung disease, immunosuppression, recent exposures, meds, surgery, smoking, alcohol, symptoms like fatigue, pain.

And objectively.

Vital signs, especially O2 sat and respiratory rate, mental status changes, how much effort they're using to breathe, listen to those lungs, check for asymmetric chest movement, note sputum characteristics.

Then your priority interventions.

Monitor that respiratory status constantly.

Oxygen therapy as needed.

Give antibiotics on time.

Keep the head of the bed up at least 30 degrees.

Turn and reposition Q2 hours.

Encourage deep breathing, coughing, use of the incentive spirometer.

Manage pains so they can cough effectively.

Treat fever.

And it's collaborative too, right?

Working with RTs, dietitians.

Absolutely.

And patient education is huge.

Hand washing.

Importance of vaccines.

Pneumococcal vaccines like PCV13 and PPSA23.

And the annual flu shot.

Table 30 .5 details the recommendations.

Smoking cessation resources.

And drilling home the need to finish the entire course of antibiotics even if they feel better.

So important.

Okay, let's shift gears to tuberculosis.

TB.

Caused by mycobacterium tuberculosis.

A massive global health issue.

Maybe a quarter of the world's population is infected.

And the link with HIV and the rise of drug resistant strains keeps it a major challenge.

It really does.

And there are significant health equity issues too, as highlighted in box 30 .2.

TB disproportionately affects racial and ethnic minorities in underserved populations.

How it spreads.

Airborne droplets.

Talking, sneezing, singing, coughing.

But it usually requires close, frequent or prolonged exposure.

Not like catching a cold from a casual encounter.

And the bacteria love oxygen, right?

So they head for the lungs.

They're aero -philic, yes.

They typically lodge in the upper lobes.

The body's immune system usually walls them off into a granuloma, which can calcify, that's the GONE lesion you might see on an x -ray.

Most people contained it there.

But maybe 5 -10 % of infected people will develop active TB disease later in life.

Sometimes years later.

Especially if their immune system gets compromised.

And you mentioned drug resistant.

Yes.

Multi -drug resistant TB, MDR -TB,

and extensively drug resistant TB, XDR -TB, are huge problems.

Often due to patients not taking their meds correctly or for the full duration, or sometimes incorrect prescribing in the first place.

This highlights the need for directly observed therapy, DOT.

Absolutely critical.

Having a healthcare worker watch the patient swallow every dose ensures adherence, which is essential for cure and preventing resistance.

Box 30 .3 talks about who benefits most from DOT.

Okay, so table 30 .9 and 30 .0 help classify TB.

There's primary infection, latent TB infection or LTBI, and active TB disease, which can be primary or reactivation.

The key distinction for LTBI is, the person is infected, they'll have a positive skin test or blood test, but they have no symptoms, a normal chest x -ray usually, and they cannot spread the bacteria to others.

But they can develop active TB later.

Correct.

That's why treating LTBI is so important for TB control, it prevents future active cases.

So what are the symptoms of active TB?

They often develop gradually, maybe two, three weeks after infection or reactivation.

Starts with a dry cough that becomes productive, often mucoid or mucopurulent sputum.

Then the classic constitutional symptoms, fatigue, malaise, unexplained weight loss, low -grade fevers, and night sweats.

Those drenching night sweats are quite characteristic.

Dyspnea and coughing up blood, hemophysis are usually later signs.

Generally, yes, indicating more advanced disease.

And again, a crucial point, watch out for atypical presentations.

Immuno -compromised patients, like those with HIV or older adults, might not have fever.

They might just present with confusion or other vague symptoms.

Renal TB might cause dysphoria, bone TB, severe pain.

Always consider TB in these groups, even without the classic picture.

Diagnostics them.

Table 30 .1 covers this.

The MANTU test, or tuberculin skin test, TST, is common.

Right.

Injecting purified protein derivative, PPD, intradermally.

You read it 48, 72 hours later, looking for induration that raised hardened area, not just redness.

The size considered positive depends on the person's risk factors.

And the two -step testing for healthcare workers.

Yeah, that's for baseline screening to avoid misinterpreting a boosted reaction later on.

Then there are the blood tests, the IGRAs.

Interferon gamma release assays, like quantiferon TB gold or TCHE TB.

Advantages are, they only need one visit.

Results aren't affected by prior BCG vaccine, and reading is objective.

But here's the critical learning point.

Neither the TST nor the IGRAs can distinguish between latent TB infection, LTBI, and active TB disease.

They just tell you if the person has been infected at some point.

So you still need other tests for active disease.

Definitely.

Chest x -ray might show infiltrates, cavity lesions, especially in the upper lobes, but it's not definitive.

The gold standard for diagnosing active pulmonary TB is a sputum culture for acid -fast bacilli, AFB.

And you need multiple samples.

Yes.

Typically, three consecutive sputum specimens collected early in the morning for AFB smear and culture.

Culture takes weeks, but the smear can give a quicker preliminary result.

In interprofessional care, most patients can be treated as outpatients.

If they have a positive sputum smear, they're considered infectious for the first two weeks or so of effective treatment.

So public health follow -up is crucial.

Drug therapy is intense.

Table 30 .12 and 30 .13 lay it out.

For active disease, it's always multiple drugs to prevent resistance.

Typically, a four -drug initial phase for two months, usually isoniazid, INH, rifampin, RIF, pyrazinamide, PZA,

and ethybutyl, EMB,

followed by a continuation phase, often just INH and RIF, for another four to seven months.

It's a long haul.

Which again highlights the importance of DOT.

Absolutely.

Major side effects nurses need to monitor for include non -viral hepatitis, especially with INH, RIF, and PZA.

Liver function tests are essential.

Rifampin famously turns body fluids, urine, sweat, tears, sputum orange.

You need to warn patients about that so they don't panic.

Good heads up.

And for latent TB?

LTBI treatment is simpler, usually just one drug to prevent progression.

Nine months of daily isoniazid is a common regimen, though shorter rifampin -based regimens are also used now, as shown in table 30 .14.

Nursing management focuses on health promotion, screening high -risk groups, treating LTBI, addressing those social determinants like poverty, and overcrowding that fuel TB spread.

In acute care, if pulmonary or laryngeal TB is suspected or confirmed, it's airborne isolation.

That means a private, negative room and staff must wear N95 respirators when entering.

Strict handwashing and cough etiquette are vital.

And in ambulatory care?

Ensuring patients adhere to meds, teaching them how to minimize exposure to others, good ventilation at home, covering mouth when coughing,

monitoring for side effects, and collecting those follow -up sputum cultures monthly until they have two consecutive negative results, and working closely with the public health department for contact tracing and DOT.

Briefly, you also mentioned atypical mycobacteria and fungal infections?

Right, just quickly, atypical mycobacteria are found in tap water, soil.

They're not usually spread person -to -person like TB.

They often affect immunocompromised people.

Pulmonary fungal infections come from inhaling spores like cassidioids in the southwest U .S.

again, not usually person -to -person.

Different diagnostics, antifungal meds needed.

Okay, let's touch on lung abscess.

A lung abscess is basically necrosis, or death, of lung tissue, forming a cavity that fills with pus.

Often results from aspiration to bacteria, especially from the mouth, if someone has poor dental hygiene or periodontal disease.

Other causes.

IV drug use, cancer, pulmonary emboli can sometimes lead to it.

Clinical signs, usually slow onset, right?

Weeks to months.

Yeah.

The classic sign is cough -producing purulent sputum that's often described as foul -smelling and foul -tasting, maybe dark brown.

Hemoptysis, coughing up blood is also common.

Fever, chills, night sweats, weakness too.

Assessment might show decreased breath sounds initially, maybe crackles later.

Treatment.

Prompt IV antibiotics are key.

Clinomycin is often used first line.

Patient education needs to stress taking the full, often prolonged course of antibiotics and addressing the underlying costs like getting dental care.

Sometimes percutaneous drainage or even surgery like lobectomy might be needed if antibiotics don't work.

Okay, let's shift focus now to restrictive disorders and trauma, things that limit lung movement.

Restrictive disorders mean the chest wall or diaphragm can't move properly, or the lungs can't expand fully, leading to reduced total lung capacity.

Like atelectasis.

Exactly.

Collapsed, airless alveoli.

Super common post -operatively or in anyone bedridden.

This is where basic nursing care is so important for prevention.

Deep breathing, coughing, instead of spirometry, getting patients moving early.

Inflammation of the pleura causes sharp stabbing chest pain, especially on inspiration.

Treatment focuses on the underlying cause and pain relief, maybe NSAIDs teaching patients to splint their ribcage when they cough.

And pleural effusion, fluid in that pleural space.

Yep, and have normal collection of fluid.

It's usually a sign of something else going on, heart failure, infection like pneumonia, cancer, liver disease.

We differentiate between transitive effusions usually clear, low protein from things like heart failure and exotative, evasive effusions, cloudy, high protein, often from inflammation or infection.

Empyoma is when that fluid is frank pus.

Symptoms often include dyspnea, cough, maybe some chest pain.

Assessment shows decreased breath sounds and dullness when you percuss over the fluid.

Management is about treating the cause.

Thoracentesis training the fluid with a needle can be diagnostic and therapeutic.

For larger or recurrent effusions, a chest tube might be placed.

Sometimes chemical pleurodesis is done using an irritant -like talc to make the pleural layers stick together and prevent fluid recalculating.

That often requires the nurse to reposition the patient frequently after the chemical is instilled.

Chest trauma, always serious, can be blunt or penetrating.

Absolutely.

Initial management follows ABC's airway breathing circulation, high flow to IV access.

If it's a sucking chest wound, cover it with a non -porous dressing taped on three sides.

This allows air to escape during expiration but prevents it entering during inspiration.

Stabilize any impaled objects, don't pull them out.

Table 30 .17 outlines emergency steps.

Fractured ribs are the most common type, right?

Pain is the big issue.

Pain, especially with breathing or coughing, leading to shallow breaths.

Treatment is all about pain control and NSAIDs.

Maybe opioids carefully to allow for deep breathing and coughing to prevent atelectasis and pneumonia.

And importantly, no chest strapping or binders.

Definitely not.

That restricts expansion and increases risks.

Old practice, now discouraged.

What about flail chest?

That sounds bad.

It is.

It's when you have three or more consecutive ribs fractured in two or more places.

This creates a segment of the chest wall that's unstable, no longer connected to the rest of the rib cage.

And the hallmark sign is?

Paradoxical movement.

This is where it gets really interesting visually.

The flail segment moves in during inspiration, when the rest of the chest moves out and bulges out during expiration.

Opposite of normal.

Wow, other signs.

Rapid shallow breathing, tachycardia, difficulty breathing, asymmetric chest movement.

Treatment involves ensuring adequate ventilation,

oxygen, pain control.

Sometimes mechanical ventilation is needed to stabilize the chest wall internally or surgical fixation.

Okay, let's talk pneumothorax, error in the plural space.

Right.

Causes partial or complete lung collapse because the negative pressure that normally keeps the lung inflated is lost.

Can be open from an external wound or closed no external wound.

And different types.

Yes.

Spontaneous pneumothorax happens when a small air sack, a blib on the lung surface ruptures.

More common in tall, thin young men, smokers, or those with underlying lung disease.

Iatrogenic pneumothorax is caused by a medical procedure like a lung biopsy, central line insertion, even mechanical ventilation.

And then there's tension pneumothorax.

You mentioned this is an emergency.

Medical emergency.

Absolutely.

This is figure 30 .6 in Lewis.

Air enters the plural space,

often through a chest wall injury or a lung injury, but it can't escape like a one -way valve.

Pressure builds up rapidly in the affected side.

It collapses the lung completely.

And this is the critical part.

It pushes the mediastinum, the heart, and great vessels over to the unaffected side.

Compressing the good lung and the heart.

Exactly.

It drastically reduces venous return and cardiac output.

Life -threatening.

You'll see severe respiratory distress, tachycardia, hypotension.

Tracheal deviation away from the affected side is a very late and ominous sign.

How do you manage it?

Small, simple pneumothorax might just need observation.

An open chest wound needs that vent dressing we talked about taped on three sides.

But the definitive treatment for most significant pneumothoraces is a chest tube connected to water -sealed drainage to remove the oar and allow the lung to re -expand.

For tension pneumothorax, immediate intervention is needed.

Medial decompression, inserting a large bore needle into the second intercostal space, make clavicular line to release the trapped air urgently,

followed by chest tube insertion.

And quickly, hemothorax and chylothorax.

Hemothorax is blood in the plural space, usually from trauma.

Chylothorax is lymphatic fluid, often from trauma or malignancy affecting the thoracic duct.

Both usually require chest tube drainage.

Okay, let's shift to vascular and environmental lung issues.

Pulmonary edema.

Abnormal fluid buildup in the alveoli and interstitial spaces of the lungs.

Often a life -threatening complication, most commonly from left -sided heart failure, but other causes too.

Manifestations are pretty dramatic.

Often, yeah.

Severe dyspnea, feeling like they're drowning.

Diaphoresis, maybe wheezing.

And that classic frothy, often pink -tinged sputum.

Treatment aims to improve oxygenation, reduce fluid high Fowler's position.

Oxygen, diuretics are key.

Sometimes morphine, vasodilators, or vasopressors, depending on the cause and hemodynamics.

Now, pulmonary embolism, PE, a big one.

Lockage of pulmonary arteries.

Usually a thrombus, a blood clot that formed elsewhere, typically a deep vein thrombosis, DVT, in the legs and travel to the lungs.

The term venous thromboembolism, VTE, covers both DVT and PE.

Risk factors are key for prevention here.

Table 30 .19 lists many.

Crucial.

Immobility or reduced mobility is huge.

Recent surgery, especially orthopedic, abdominal, pelvic, history VTE, cancer, obesity, hormones like oral contraceptives or hormone therapy, smoking,

heart failure, atrial fibrillation, pregnancy, long travel.

Identifying patients with these risks allows for prophylaxis.

Clinical signs are notoriously tricky, right?

Varied and nonspecific.

Very tricky.

Dyspnea is the most common symptom, often sudden onset.

But patients might also have tachypnea, cough, chest pain, often pleuretic, maybe hemoptysis, crackles, or wheezing on auscultation, tachycardia, low -grade fever.

That's the alarming sign.

A massive PE can cause sudden collapse, shock.

So hypotension, pale, diaphoretic, maybe acute mental status changes.

And sometimes patients report this intense feeling of anxiety or impending doom.

That's a serious sign.

Complications.

Pulmonary infarction, death of lung tissue due to block blood supply can happen, especially with larger emboli.

And recurrent or chronic PEs can lead to pulmonary hypertension, which is high blood pressure in the pulmonary arteries.

Diagnostics table 30 .2, D -dimer test.

It measures fibrin degradation products.

If it's normal, it helps rule out PE in low -risk patients.

But if it's elevated, it's nonspecific.

Could be PE, but also many other things like infection, recent surgery, cancer.

So the gold standard is?

Spiral CT angiography, or CTA.

It provides a detailed image of the pulmonary arteries using IB contrast.

If contrast is contraindicated, like in renal failure or allergy, a ventilation perfusion, VQ scan, is an alternative.

ABGs often show unexplained hypoxemia.

ECG might show tachycardia or signs of right heart strain.

Interprofessional care needs to be prompt.

Absolutely.

Mortality is high if untreated.

Supportive care includes oxygen, maybe mechanical ventilation if needed.

Pain management.

Drug therapy is the mainstay.

Immediate anticoagulation is crucial.

Low molecular weight heparin, like an oxaparin or unfractionated heparin, are started right away, followed by long -term anticoagulation, usually with warfarin or a direct oral anticoagulant, DOAC, for at least three months, often longer.

Fibrinolytics sometimes.

Yes.

Clot -busting drugs like Ultaplase, TPA, might be used for hemodynamically unstable patients with massive PE, but there's a higher risk of bleeding.

Surgical options.

Pulmonary embolectomy, surgically removing the clot, is reserved for massive PE if fibrinolytics are contraindicated or failed.

More common is placing an inferior viancava, IVC filter, like the one in figure 30 .8.

It's a small filter placed in the IVC to trap large clots traveling from the legs before they reach the lungs.

Used for patients who can't take anticoagulants or have recurrent PEs despite anticoagulation.

Nursing management.

Starts with prevention, right?

Prevention is paramount.

DVT prophylaxis for at -risk patients.

Sequential compression devices, SCDs, early ambulation after surgery, anticoagulant prophylaxis if ordered.

And for a patient with an acute PE.

Keep them on bed rest initially, usually in semi -fowler's position to help breathing.

Monitor vital signs frequently, cardiac rhythm, oxygen saturation, ABGs.

Watch for any signs of bleeding if they're on anticoagulants or fibrinolytics.

Monitor lab results like INR for warfarin, APTT for heparin, platelet counts.

Provide emotional support, it's a scary event.

And patient education for discharge is critical.

Understanding their anticoagulant therapy.

Need for follow -up monitoring.

Recognizing signs of recurrence or bleeding.

Okay, briefly on pulmonary hypertension and core pulmonary.

Pulmonary hypertension pH is just elevated pressure in the pulmonary arteries.

Can be caused by many things left.

Heart disease, chronic lung disease like COPD, chronic PEs.

Sometimes it's idiopathic, meaning the cause is unknown.

That's idiopathic pulmonary arterial hypertension, IPAH.

And core pulmonary.

That's specifically enlargement of the right ventricle of the heart caused by a primary disorder of the respiratory system like COPD or severe pH.

Figure 30 .9.

The right heart has to pump harder against the high pressure in the lungs and it eventually fails.

Symptoms can be subtle.

Often masked by the underlying lung disease.

Maybe fatigue, dyspnea, exertion, chest pain.

Later signs of right heart failure might appear, like peripheral edema, JVD sites.

Management involves treating the underlying lung disorder.

Long -term oxygen therapy is key for many as it helps reduce pulmonary vasoconstriction caused by hypoxemia.

And environmental lung diseases from inhaled dusts or chemicals.

Yeah, these often have a long latency period.

Symptoms might not show up for 10, 15 years or more after exposure stops.

Like pneumoconiosis.

Right, that's the general term for lung diseases caused by inhaling mineral or metal dusts.

Examples are silicosis from silica dust,

asbestosis from asbestos fibers, coal workers pneumoconiosis or black lung.

Asbestos is particularly nasty linked not just to lung fibrosis but also lung cancer and mesothelioma, cancer of the pleura.

Chemical pneumonitis.

From inhaling toxic chemical fumes.

Can cause acute lung injury or chronic problems like bronchiolitis sublitans.

And hypersensitivity pneumonitis.

That's an allergic immune reaction to inhaled organic dusts or antigens.

Think farmer's lung from moldy hay or bird fancier's lung from bird droppings or feathers.

Manifestations are usually shortness of breath, cough, maybe wheezing, weight loss.

Yes, developing gradually over years.

Complications can include COPD, pulmonary fibrosis, lung cancer, and corpulmenal.

Prevention is the absolute key here.

Using appropriate masks and respirators, PPE,

good workplace ventilation, avoiding smoking.

Treatment focuses on?

Early diagnosis, stopping exposure if possible.

Oxygen therapy, maybe bronchodilators or corticosteroids to manage symptoms.

Pulmonary rehab can help improve function.

And keeping up with vaccinations like flu and pneumococcal is important for these patients.

Okay, let's move into oncologic problems and advanced treatments.

Starting briefly with lung transplantation.

Lung transplant is an option for some patients with end stage lung disease like severe COPD, idiopathic pulmonary fibrosis, cystic fibrosis, severe IPAH.

But donor lungs are scarce.

Patients undergo extensive evaluation.

There are strict contraindications.

A lung allocation score, LAS, helps prioritize recipients based on urgency and expected benefit.

Surgical options include single lung, bilateral, both lungs, heart -lung transplant, or even lobar transplants using lobes from living donors.

Post -op care is intense.

Mechanical ventilation initially, then aggressive pulmonary hygiene.

And lifelong immunosuppression.

Absolutely critical to prevent rejection.

Usually a combination of drugs like tacrolimus, mycophenolipmofel, and prednisone.

But this increases the risk of infection, which is actually the leading cause of death post -transplant.

Rejection is also a major concern.

Yes.

Acute rejection often happens in the first 5 -10 days, presenting with low -grade fever, fatigue, dyspnea, dry cough, falling O2 sats.

Diagnosis is confirmed by transbronchial biopsy.

Chronic rejection, called bronchiolitis obliterans, is a gradual scarring of the small airways, leading to progressive airflow obstruction.

Harder to treat.

Patient education on medication adherence, infection prevention, monitoring symptoms, and using home spirometry is vital.

Now let's tackle lung cancer.

Still the leading cause of cancer deaths in the U .S.

for both men and women.

Sadly, yes.

More than breast, prostate, and colon cancer combined.

Although outcomes are improving with newer treatments, the mortality rate remains high.

Etiology overwhelmingly linked to smoking.

About 80 -90 % of cases.

Risk is related to how much and how long someone smoked.

Quitting helps risk decreases over time, but it takes 10 -15 years off cigarettes to approach non -smoker risk levels.

Other risks?

Secondhand smoke, absolutely.

Air pollution.

Radiation exposure, like radon gas in homes.

Asbestos.

Other industrial agents.

Family history plays a role too.

And there are disparities.

Boxes 30 .5 and 30 .6 discuss differences related to biological sex and race ethnicity.

Pathophysiology starts with mutated lung cells, usually epithelial cells.

Often grows slowly, taking maybe 8 -10 years to reach 1 cm, the size detectable on x -ray.

But it tends to metastasize early, often spreading to lymph nodes, liver, brain, bones, and adrenal glands, even before diagnosis.

Two main types, right?

Table 30 .24 outlines them.

Broadly, yes.

Non -small cell lung cancer, NSCLC, accounts for about 84%.

This includes several subtypes.

Adenocarcinoma is the most common, especially in people who haven't smoked, often found in outer lung areas.

Squamous cell carcinoma tends to be more central, causes earlier symptoms like cough and hemoptysis.

Large cell carcinoma is less common, grows rapidly, highly metastatic.

And the other type, small cell lung cancer, SCLC.

About 13%.

SCLC is very aggressive, grows rapidly, metastasizes very early, often to the brain.

It's strongly associated with smoking and frequently causes perineoplastic syndromes, where the tumor secretes hormones or substances, causing symptoms elsewhere like SIDH or hypercalcemia.

Clinical signs often appear late and are nonspecific.

Unfortunately, yes.

A persistent cost that doesn't go away or changes is often the earliest most common symptom.

Others include dyspnea, wheezing, maybe blood tims, sputum, chest pain.

Later symptoms.

Anorexia, fatigue, significant weight loss, nausea, vomiting, hoarseness if the laryngeal nerve is involved, dysphagia if the esophagus is compressed.

Symptoms depend a lot on location and spread.

Diagnostics.

Table 30 .25.

Chest x -ray is usually the first test if symptoms arise.

CT scan gives much more detail about the mass.

Lymph nodes.

Definitive diagnosis requires a biopsy.

Always.

Getting a tissue sample is essential.

Can be done via bronchoscopy, CT guided needle biopsy, or other methods depending on tumor location.

Staging workup uses peaky scans, MRI, especially for brain meds.

Bone scans to see if and where it has spread.

And screening.

Yes, annual low -dose CT screening is recommended for certain high -risk individuals.

Adults aged 50 -80 with at least a 20 -pack year smoking history who currently smoke or quit within the last 15 years.

It can detect cancers earlier when they're more treatable.

Staging is crucial for treatment planning.

And SCLC uses the TNM system.

State designed to AIAA might be candidates for surgery.

Stage IIAB and OIV are generally considered advanced and treated non -surgically.

SCLC is different.

Because it spreads so early, it's always considered systemic.

It's staged simply as limited stage can find one hemothorax and regional nodes or extensive stage spread beyond that.

This aggressive nature totally changes the treatment approach compared to NSCLC.

So treatment.

For NSCSE, surgery might be an option.

For earlier stages, yes.

Surgical resection, maybe lobectomy, removing a lobe, or pneumonectomy, removing a whole lung, offers the best chance for cure.

Surgery is generally not used for SCLC because it's already systemic at diagnosis.

Other treatments.

Radiation.

Radiation can be used curatively for early stage NSCLC if surgery is impossible.

Or adjuvantly after surgery.

Or palliatively to relieve symptoms like pain or obstruction.

Stereotactic body radiotherapy, SBRT, uses high dose focused radiation for small early stage tumors.

TEMO therapy.

TEMO is the main treatment for SCLC.

It's also used as adjunant therapy for NSCLC after surgery or as primary treatment for advanced NSCLC, often combined with other therapies.

And newer therapies.

Targeted therapy and immunotherapy.

Big advances here.

Targeted therapies are drugs that target specific genetic mutations or proteins driving cancer growth like EGFR inhibitors or ALK inhibitors for NSCLC with those mutations.

Often have fewer side effects than traditional chemo.

Immunotherapy drugs like PD -1 or PD -L1 inhibitors, Giflac, Nivalihab, Bimalizumab, work by helping the patient's own immune system recognize and attack the cancer cells.

They've significantly improved outcomes for many patients with advanced NSCLC and extensive stage SCLC.

Other things like prophylactic cranial radiation for SCLC?

Yes, because SCLC has such a high rate of brain metastasis, radiation to the brain is often given even if no meds are visible to prevent them from developing.

Other options for symptom control might include bronchoscopic laser therapy or stenting to open airways or radiofrequency ablation for small tumors.

Nursing management table 30 .27 emphasizes assessment.

Crucial to understand not just the physical symptoms but also the patients and caregivers understanding anxiety level support systems.

Subjectively get that smoking history, exposure history, ask about fatigue, cough, pain, coping.

Objectively look for those signs, maybe weight loss, confusion, possible brain mets, lymph node swelling, wheezing, clubbing of fingers, a late sign, review diagnostic results.

Health promotion is still key, preventing smoking initiation, helping people quit.

Even after diagnosis, reducing smoking can improve treatment response and quality of life.

Promote smoke -free environments and care.

Provide support during the diagnostic workup, which can be very stressful.

Help manage symptoms like dyspnea, oxygen, positioning, meds, cough, pain.

Monitor closely for side effects of treatment, chemo, radiation, immunotherapy, all have potential toxicity.

Amulatory and home care.

Continued support for smoking cessation, education on safe O2 use if prescribed.

As the disease progresses, focus shifts more towards palliative care managing symptoms, improving quality of life.

Collaboration with palliative care teams, social workers, spiritual advisors becomes essential for holistic support, especially end -of -life care.

And that brings up that tough question.

How do you, as the nurse, support patient autonomy, maybe their choice to continue smoking while still advocating for their best possible health and quality of life?

It's a real ethical challenge sometimes.

It really is.

Requires empathy, non -judgmental communication, and focusing on achievable goals that align with the patient's values.

Wow.

Okay.

So what does this all mean?

We've covered a huge amount of ground in this deep dive.

Infections like bronchitis, pneumonia, TB, traumatic issues like pneumothorax, critical vascular events like PE, environmental exposures, and the complexities of lung cancer and transplantation.

Yeah.

It's a vast landscape.

But the common thread is their impact on that fundamental process of gas exchange, which is essential for life.

So the key takeaways for nursing students.

I think number one is the power of meticulous assessment.

Really listening to your patient, listening to their lungs, recognizing subtle changes, especially in vulnerable populations.

Number two,

understanding the why the pathophysiology helps you anticipate problems and prioritize your actions.

Three, always be thinking about potential complications, resistance, respiratory failure, side effects of treatment.

And finally, your interventions, oxygen positioning, meds, mobility, education need to be timely and evidence -based.

Patient education and collaborative care are woven through all of it.

It's about connecting all those dots for really effective patient -centered nursing.

Excellent summary.

So as you continue your nursing journey, here's something to think about.

Those subtle early signs of lower respiratory trouble, maybe slight confusion in an older patient, a new onset cough, mild dyspnea.

How can you sharpen your deep dive level of observation to catch those nuanced indicators early?

Catching those might just make a life -changing difference.

Thank you for joining us on this deep dive.